United States: FTC Issues Updated Media Guidance For Screening Fake Weight Loss Claims

On January 7, 2014, the Federal Trade Commission announced "Operation Failed Resolution", targeting false and deceptive claims made by marketers of weight loss products.  As part of this initiative, the FTC issued updated guidance for use by the media to help them spot phony weight-loss claims when screening ads for publication.  Along with the release of this media guidance, the FTC also announced the settlement of four enforcement actions against companies marketing foods, cosmetics or dietary supplements.  In connection with these weight-loss and similar cases, there appears to be disagreement among the Commissioners as to a substantiation rule that would require two "randomized controlled trials" to substantiate health and disease-related claims.


The FTC filed a complaint against Sensa for marketing its product as a food that you could "sprinkle on [your food] to take the weight off."  Sensa represented that clinical studies supported the weight losses claimed.  However, according to the FTC, the company did not have the science to back up these claims.  Alleged deficiencies in the clinical studies include lack of blinding, the lack of a placebo control, failure to account for subjects that do not complete the study, and failure to monitor the subjects' diet and exercise (weights were self-reported).  In addition, Sensa allegedly failed to disclose that its consumer endorsers had been offered compensation in exchange for their endorsement.  According to the complaint, sales of Sensa in the United States totaled nearly $364 million for the period from 2008-2012.  Sensa agreed to pay 26.5 million dollars into a fund to be used for consumer redress.


The FTC alleged that L'Occitane marketed certain skin cream products as "cellulite fighters" with claims that they "visibly reduce the appearance of cellulite" and "trim 1.3 inches in just 4 weeks" off thighs.  L'Occitane claimed that it had clinical evidence to support these claims.  However, the FTC alleged that the clinical evidence failed to substantiate the claims.  According to the FTC, the evidence relied on consisted primarily of results from a single unblended, uncontrolled clinical trial and L'Occitane exaggerated the results of the trial.  According to the FTC's complaint, the average reported reduction in thigh circumference was less than a quarter of an inch, and only one participant (out of fifty) reportedly achieved a reduction of 1.3 inches.

L'Occitane agreed to pay $450,000 pursuant to the FTC settlement into a fund to be used for consumer redress.

HCG Diet Direct

The third settlement announced involved HCG's Diet Direct product.  Allegedly, the company marketed Diet Direct as a  homeopathic weight-loss product.  Diet Direct purportedly contained human chorionic gonadotropin; and HCG claimed that consumers could lose as much as a pound a day merely by putting drops under the tongue before meals.  The FTC alleged that the weight loss claims touting Diet Direct were either false or unsubstantiated.  Additionally, the FTC alleged that HCG failed to disclose that certain of the people providing testimonials in Diet Direct ads were compensated for their endorsements or were relatives of company representatives.

LeanSpa, LLC

The FTC's fourth settlement involves LeanSpa, LLC, and other related companies.  LeanSpa allegedly deceptively promoted acai berry and "colon cleanse" weight-loss supplements marketed under various brand names through fake news websites.  According to the FTC, among other allegedly deceptive practices, the marketers used domain names that appeared to be objective news or health websites (e.g., "channel8health.com") and aired reports that were falsely represented to have aired on major broadcast and cable networks.  The reports were authored by purported testers of the LeanSpa products who reported dramatic and positive results.

The FTC reached a settlement pursuant to which, in addition to a variety of injunctive relief, the respondents surrendered assets worth approximately $7 million.

Updated guidance for media outlets on spotting bogus weight-loss claims in advertising

As part of its initiative, the FTC also issued an updated guidance for media to recognize bogus weight loss claims, "Gut Check."  This guidance instructs media outlets on how to screen advertisements for facially deceptive weight loss claims, so that they will refuse to publish or to air deceptive ads.  Although the FTC has the authority to sue media outlets for running deceptive ads, statements made at the FTC's press conference announcing this guidance indicate that the FTC does not intend to pursue action against media outlets.  Instead, the guidance appears designed to encourage the media's voluntary cooperation.  The updated guidance includes tips on testimonials and an online tutorial.  It also identifies seven representations believed to be inherently deceptive and the media should avoid airing.  These "Gut Check" claims are claims that a product:

  1. causes weight loss of two pounds or more a week for a month or more without diet or exercise;
  2. causes substantial weight loss no matter what or how much the consumer eats;
  3. causes permanent weight loss even after the consumer stops using the product;
  4. blocks the absorption of fat or calories to enable consumers to lose substantial weight;
  5. safely enables consumers to lose more than three pounds a week for more than four weeks;
  6. causes substantial weight loss for all users; and
  7. causes substantial weight loss by wearing a product on the body or rubbing it into the skin.

As part of this campaign, the FTC will send guidance letters to 75 media outlets to assist them in recognizing bogus weight loss claims.

Commissioners question the "standard" requirements for two randomized clinical trials

On the same day that the FTC announced the settlements in the weight loss cases, it also announced a settlement against GeneLink concerning the advertising of a customized dietary supplements to treat diseases.

The weight-loss and Genelink settlements define "competent and reliable evidence" for the relevant products as requiring two well-controlled human clinical studies (randomized controlled trials or RCT's).  However, there appears to be disagreement within the Commission about whether this high standard is justified under all circumstances.  Notably, Commissioners Ohlhausen and Wright issued separate statements in which they, among other things, raise questions regarding the requirement for two RCT's to satisfy the standard of "competent and reliable scientific evidence" for other than weight loss claims.  Commissioner Wright states that "t]he optimal amount and type of evidence to substantiate a future claim will vary from case to case," and urges the Commission to consider whether this requirement "strikes the right balance between deterring deceptive advertising and preserving the consumers the benefits of truthful claims. Commissioner Ohlhausen similarly expresses concern that the requirement of 2 RCTs has become a "standard requirement for health-and disease-related claims for a wide array of products," cautioning that "[a]dopting a one-size-fits-all approach to substantiation by imposing such rigorous and possibly costly requirements for ...a broad category of health-and disease-related claims may, in many instances, prevent useful information from reaching consumers in the marketplace and ultimately make consumers worse off."  She advocates a carful application of the factors enunciated Pfizer, Inc.,  81 F.T.C. 23 (1972), rather than requiring two RCTs without consideration of the particular circumstances in the case at issue.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
30 Jan 2018, Webinar, Los Angeles, United States

Augmented by guest lecturers from government and the private sector, this webinar series will combine teaching of the key rules with war stories from the front lines and practical advice from experienced practitioners.

30 Jan 2018, Webinar, Los Angeles, United States

Liisa Thomas will present “Preparing for a Breach When It Happens” at the Data Privacy & Security Summit 2018 in Washington DC.

1 Feb 2018, Seminar, California, United States

The annual PIHRA Legal Update Seminars provides you with the latest California employment law related updates, compliance and regulatory issues, and the opportunity to network with legal practitioners and HR professionals.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions